Complete list of Publications available here

Google Scholar

Recent Publications 

About population structure

  1. Paschou P, Drineas P, Yannaki E, Razou A, Kanaki K, Tsetsos F , Padmanabhuni SS, Michalodimitrakis M, Renda MC, Pavlovic S, Anagnostopoulos A, Stamatoyannopoulos JA, Kidd KK, Stamatoyannopoulos G. A maritime route of colonization of Europe. Proceedings of the National Academy of Sciences USA, in press. (FULL TEXT)
  2. Hughey JR, Paschou P, Drineas P, Mastropaolo D, Lotakis DM, Navas PA, Michalodimitrakis M, Stamatoyannopoulos JA, Stamatoyannopoulos G (2013). A European Population in the Minoan Bronze Age Crete. Nature Communications, 4: 1861. (FULL TEXT)
  3. Stathias V, Sotiris G, Karagiannidis I, Bourikas G, Martinis G, Papazoglou D, Tavridou A, Papanas N, Maltezos E, Theodoridis M, Vargemezis V, Manolopoulos VG, Speed WC, Kidd JR, Kidd KK, Drineas P, Paschou P (2012). Exploring genomic structure differences and similarities between the Greek and European HapMap populations; implications for association studies. Annals of Human Genetics, 76(6): 472-483. (PDF)
  4. Donnelly MP, Paschou P, Grigorenko E, Gurwitz D, Barta C, Lu RB, Zhukova OV, Kim JJ, Siniscalco M, New M, Li H, Kajuna SL, Manolopoulos VG, Speed WC, Pakstis AJ, Kidd JR, Kidd KK. A global view of the OCA2-HERC2 region and pigmentation. Hum Genetics, in press. (PDF)
  5. Javed A, Drineas P, Mahoney MW, Paschou P. Efficient genomewide selection of PCA-correlated tSNPs for genotype imputation. Annals of Human Genetics, 75, 707-722. (PDF)
  6. Lewis J, Abas Z, Dadousis C, Lykidis D, Paschou P, Drineas P (2011). Tracing Cattle Breeds With PCA-based Ancestry Informative SNPs. PLoS ONE 6(4):e18007. (PDF)
  7. Paschou P, Lewis J, Javed A, Drineas P (2010). Ancestry informative markers for fine-scale individual assignment to worldwide populations.  Journal of Medical Genetics 47, 835-847. (PDF)
  8. Drineas P, Lewis J, Paschou P. Inferring Geographic Coordinates of Origin for Europeans using Small Panels of Ancestry Informative Markers. PLoS ONE 5(8):e11892. (PDF)
  9. Donnelly MP, Paschou P, Grigorenko E, Gurwitz D, Mehdi SQ, Kajuna SL, Barta C, Kungulilo S, Karoma NJ, Lu RB, Zhukova OV, Kim JJ, Comas D, Siniscalco M, New M, Li P, Li H, Manolopoulos VG, Speed WC, Rajeevan H, Pakstis AJ, Kidd JR, Kidd KK (2010). The distribution and most recent common ancestor of the 17q21 inversion in humans. Am J Hum Genet 86, 161-171. (PDF)
  10. Paschou P, Drineas P, Lewis J, Nievergelt CM, Nickerson DA, Smith JD, Ridker PM, Chasman DI, Krauss RM, Ziv E (2008). Tracing sub-structure in the European American population with PCA-informative markers. PLoS Genetics 4:e1000114. (PDF)
  11. Paschou P, Ziv E, Burchard EG, ChoudryS, Rodriguez-Cintron W, Mahoney MW,   Drineas P (2007). PCA-correlated SNPs for structure identification in worldwide human populations. PLoS Genetics 3, e160. (PDF)
  12. Paschou P, Mahoney M, Pakstis A, Kidd JR, Kidd KK, Drineas P (2007). Inter- and intrapopulation genotype reconstruction from tagging SNPs. Genome Research 17, 96-107. (PDF)

About Tourette Syndrome and psychiatric genetics

  1. Tümer Z, Bertelsen B, Melchior L, Jensen L, Groth C, Glenthĝj B, Rizzo R, Mol Debes N, Skov L, Brĝndum-Nielsen K, Paschou P, Silahtaroglu A (2014). Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome. European Journal of Human Genetics, in press 
  2. Karagiannidis I, Dehning S, Sandor P, Tarnok Z, Rizzo R, Wolanczyk T, Madruga-Garrido M, Hebebrand J, Nöthen MM, Lehmkuhl G, Farkas L, Nagy P, Szymanska U, Anastasiou Z, Stathias V, Androutsos C, Tsironi V, Koumoula A, Barta C, Zill P, Mir P, Müller N, Barr C, Paschou P (2013). Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families. J Med Genet 50(11):760-764. (PDF)
  3. Paschou P (2013). The genetic basis of Gilles de la Tourette Syndrome. Neurosci Biobehav Rev,  37(6):1026-39. (PDF)
  4. Rickards HE, Paschou P, Rizzo R, Stern JS (2013). A brief history oft he European Society for the Study of Tourette Syndrome. Behav Neurol, 27(1):3-5.
  5. Paschou P, Stylianopoulou E, Karagiannidis I, Rizzo R, Tarnok Z, Wolanczyk T, Hebebrand J, Noethen MM, Lehmkuhl G, Farkas L, Nagy P, Szymanska U, Lykidis D, Androutsos C, Tsironi V, Koumoula A, Barta C, Klidonas S, Ypsilantis P, Simopoulos C, TSGeneSEE, Skavdis G, Grigoriou M. Evaluation of LIM homeopbox genes LHX6 and LHX8 as candidates for Tourette Syndrome. Genes Brain and Behavior in press (PDF).
  6. Karagiannidis I, Rizzo R, Tarnok Z, Wolanczyk T, Hebebrand J, Noethen MM, Lehmkuhl G, Farkas L, Nagy P, Barta C, Szymanska U, Panteloglou G, Miranda DM, Feng Y, Sandor P, Barr C, Paschou P. The most common worldwide haplotype across SLITRK1 is associated with Tourette Syndrome in a large sample of families. Molecular Psychiatry in press (PDF)
  7. Müller-Vahl KR, Cath DC, Cavanna AE, Dehning S, Porta M, Robertson MM, Visser-Vandewalle V; ESSTS Guidelines Group (2011). European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation. Eur Child Adolesc Psychiatry 20(4):209-217. (PubMed)
  8. Verdellen C, van de Griendt J, Hartmann A, Murphy T; ESSTS Guidelines Group (2011). European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry. 20(4):197-207.  (PubMed)
  9. Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, Strand G, Stern JS, Termine C, Hoekstra PJ; ESSTS Guidelines Group (2011). European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry 20(4):173-196. (PDF)
  10. Cath DC, Hedderly T, Ludolph AG, Stern JS, Murphy T, Hartmann A, Czernecki V, Robertson MM, Martino D, Munchau A, Rizzo R; ESSTS Guidelines Group (2011). European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment. Eur Child Adolesc Psychiatry 20(4):155-171. (PDF)
  11. Paschou P, Feng Y, Pakstis AJ, Speed WC, DeMille MM, Kidd JR, Jaghori B, Kurlan R, Pauls DL, Sandor P, Barr CL, Kidd KK (2004). Indications of linkage and association of Gilles de la Tourette syndrome in two independent family samples: 17q25 is a putative susceptibility region. Am J Hum Genet 75,545-560. (PDF)
  12. Palmatier MA, Pakstis AJ, Speed W, Paschou P, Goldman D, Odunsi A, Okonofua F, Kajuna S, Karoma N, Kungulilo S, Grigorenko E, Zhukova OV, Bonne-Tamir B, Lu RB, Parnas J, Kidd JR, DeMille MM, Kidd KK (2004). COMT haplotypes suggest P2 promoter region relevance for schizophrenia. Mol Psychiatry 9, 859-870. (PDF)

About Diabetes

  1. Paschou P, Kukuvitis A, Yavropoulou M, Dritsoula A, Giapoutzidis V, Anastasiou O, Kazakos K. Yovos JG (2010). Genetic variation in the visfatin (PBEF1/NAMPT) gene and type 2 diabetes in the Greek population. Cytokine, 51, 25-27. (PDF)
  2. Hermann R, Bartsocas CS, Soltesz G, Vazeou A, Paschou P, Bozas E, Malamitsi-Puchner A, Simell O, Knip M, Ilonen J (2004). Genetic screening for individuals at high risk for type 1 diabetes in the general population using HLA Class II alleles as disease markers. A comparison between three European populations with variable rates of disease incidence. Diabetes Metab Res Rev 20,322-329. (PDF)
  3. Paschou P, Malamitsi A, Bozas E, Havarani B, Dokopoulou M, Bartsocas CS (2004). HLA alleles and Type 1 Diabetes in low disease incidence populations of Southern Europe; a comparison of Greeks and Albanians. Journal of Pediatric Endocrinology and Metabolism 17, 173-182. (PDF)
  4. Ilonen J, Sjoroos M, Knip M, Veijola R, Simell O, Akerblom HK, Paschou P, Bozas E, Havarani B, Malamitsi-Puchner A, Thymelli J, Vazeou A, Bartsocas CS (2002). Estimation of genetic risk for type 1 diabetes. Am J Med Genet 115, 30-36. (PDF)